EE400 Cost-Effectiveness Analysis of Fampridine for Multiple Sclerosis Treatment in China
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.648
https://www.valueinhealthjournal.com/article/S1098-3015(22)00849-X/fulltext
Title :
EE400 Cost-Effectiveness Analysis of Fampridine for Multiple Sclerosis Treatment in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00849-X&doi=10.1016/j.jval.2022.04.648
First page :
Section Title :
Open access? :
No
Section Order :
10579